Goldman Sachs Upgrades Dr Pepper Snapple (DPS) to Neutral On Commodity Relief
DPS Hot Sheet
Rating Summary:2 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Goldman Sachs upgraded Dr Pepper Snapple (NYSE: DPS) from Sell to Neutral with a price target of $41 (up from $40).
The firm said they no longer see EPS risk, as commodity relief should cushion competition and drive margin upside in 2012. The firm also said valuation is in-line with its historical average of 13x.
Goldman raised 2012E/2013E EPS estimates by $0.06/$0.05 to $2.95/$3.24 to reflect higher gross margins.
For an analyst ratings summary and ratings history on Dr Pepper Snapple click here. For more ratings news on Dr Pepper Snapple click here.
Shares of Dr Pepper Snapple closed at $38.76 yesterday, with a 52 week range of $33.68-$43.13.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
The firm said they no longer see EPS risk, as commodity relief should cushion competition and drive margin upside in 2012. The firm also said valuation is in-line with its historical average of 13x.
Goldman raised 2012E/2013E EPS estimates by $0.06/$0.05 to $2.95/$3.24 to reflect higher gross margins.
For an analyst ratings summary and ratings history on Dr Pepper Snapple click here. For more ratings news on Dr Pepper Snapple click here.
Shares of Dr Pepper Snapple closed at $38.76 yesterday, with a 52 week range of $33.68-$43.13.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong
- Goldman Sachs Upgrades L-3 Communications (LLL) to Neutral; Backlog Growth; Engility Spin A Near-Term Catalyst
- JPMorgan Upgrades Eastman Chemical (EMN) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
